Condyloma Acuminatum Ointment

KinoPharma's Condyloma Acuminatum Ointment is a topical small molecule antiviral currently in Phase 1 clinical development for the treatment of genital warts (condyloma acuminatum) caused by Human Papillomavirus (HPV) types 6 and 11. Developed in collaboration with Iwaki Pharmaceutical, the drug candidate utilizes a novel mechanism that targets human host factors to suppress viral proliferation and facilitate the repair of dysplastic tissue. This approach differs from conventional treatments that rely on physical destruction of the wart tissue, aiming instead to provide a direct pharmacological effect on the underlying viral infection in the genital and anal areas. The ointment formulation is designed for topical application to affected tissues to inhibit HPV replication and promote tissue recovery.

Other names

HPV 6/11 antiviral ointmentKinoPharma genital warts ointment